The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) closed at $43.60 down -1.58% from its previous closing price of $44.30. In other words, the price has decreased by -$1.58 from its previous closing price. On the day, 0.7 million shares were traded. AMPH stock price reached its highest trading level at $44.27 during the session, while it also had its lowest trading level at $43.34.
Ratios:
For a deeper understanding of Amphastar Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.32. For the most recent quarter (mrq), Quick Ratio is recorded 2.61 and its Current Ratio is at 3.43. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on November 22, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $55.
On March 05, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $60.
On November 17, 2023, BofA Securities started tracking the stock assigning a Neutral rating and target price of $63.BofA Securities initiated its Neutral rating on November 17, 2023, with a $63 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 12 ’24 when Zhou Rong sold 6,893 shares for $48.88 per share. The transaction valued at 336,930 led to the insider holds 118,388 shares of the business.
PRINS RICHARD K sold 5,000 shares of AMPH for $243,986 on Nov 12 ’24. The Director now owns 31,471 shares after completing the transaction at $48.80 per share. On Nov 12 ’24, another insider, Rong Zhou, who serves as the Executive Vice President of the company, bought 31,680 shares for $48.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPH now has a Market Capitalization of 2096348928 and an Enterprise Value of 2475707392. As of this moment, Amphastar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.51, and their Forward P/E ratio for the next fiscal year is 10.27. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.90 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 3.422 whereas that against EBITDA is 9.286.
Stock Price History:
Over the past 52 weeks, AMPH has reached a high of $65.92, while it has fallen to a 52-week low of $36.56. The 50-Day Moving Average of the stock is -8.49%, while the 200-Day Moving Average is calculated to be -1.64%.
Shares Statistics:
For the past three months, AMPH has traded an average of 365.61K shares per day and 427860 over the past ten days. A total of 48.37M shares are outstanding, with a floating share count of 35.94M. Insiders hold about 25.25% of the company’s shares, while institutions hold 74.69% stake in the company. Shares short for AMPH as of 1731628800 were 4235323 with a Short Ratio of 11.58, compared to 1728950400 on 4232894. Therefore, it implies a Short% of Shares Outstanding of 4235323 and a Short% of Float of 13.54.
